The health authorities of the United States came close to simply warning about the Blood-Clotting risk of the Johnson & Johnson vaccine. However, they decided to recommend pausing the usage of the vaccine out of concern doctors would improperly treat the condition. Over the previous four weeks, American health officials had become alarmed about the similar Blood-Clotting conditions in Europe related to the vaccine from AstraZeneca PLC.
The top health officials of the country agreed during the one-hour Zoom meeting to take the strongest step. It was publicly recommended to pause the vaccine’s use till probing the adverse-event cases. After the announcement, the Food and Drug Administration has been studying reports related to Blood-Clotting cases among other people who received the J&J vaccine. However, confirmation is yet to come whether they reflect the same phenomenon.
Yet, the officials are being persuaded that the six total cases reported so far are related to the shot. FDA officials are waiting to see what the vaccine panel recommends to the CDC. The two most likely options are restricting the use of the shot to an age group of men and women above 50 years.